Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The population history of northeastern Siberia since the Pleistocene.

Sikora M, Pitulko VV, Sousa VC, Allentoft ME, Vinner L, Rasmussen S, Margaryan A, de Barros Damgaard P, de la Fuente C, Renaud G, Yang MA, Fu Q, Dupanloup I, Giampoudakis K, Nogués-Bravo D, Rahbek C, Kroonen G, Peyrot M, McColl H, Vasilyev SV, Veselovskaya E, Gerasimova M, Pavlova EY, Chasnyk VG, Nikolskiy PA, Gromov AV, Khartanovich VI, Moiseyev V, Grebenyuk PS, Fedorchenko AY, Lebedintsev AI, Slobodin SB, Malyarchuk BA, Martiniano R, Meldgaard M, Arppe L, Palo JU, Sundell T, Mannermaa K, Putkonen M, Alexandersen V, Primeau C, Baimukhanov N, Malhi RS, Sjögren KG, Kristiansen K, Wessman A, Sajantila A, Lahr MM, Durbin R, Nielsen R, Meltzer DJ, Excoffier L, Willerslev E.

Nature. 2019 Jun;570(7760):182-188. doi: 10.1038/s41586-019-1279-z. Epub 2019 Jun 5.

PMID:
31168093
2.

Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.

Kostik MM, Isupova EA, Chikova IA, Dubko MF, Masalova VV, Snegireva LS, Kalashnikova OV, Chasnyk VG.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):335-341. Epub 2017 Dec 15.

PMID:
29303703
3.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

4.

Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.

Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.

PMID:
27385618
5.

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Isupova EA, Kuchinskaya EM, Glebova NI, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.

Pediatr Rheumatol Online J. 2015 Jan 23;13:4. doi: 10.1186/1546-0096-13-4. eCollection 2015.

6.

Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.

Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.

Semin Arthritis Rheum. 2015 Feb;44(4):417-22. doi: 10.1016/j.semarthrit.2014.09.004. Epub 2014 Sep 11.

PMID:
25300700
7.

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2014 Jun;73(6):1114-22. doi: 10.1136/annrheumdis-2012-203046. Epub 2013 May 21.

8.

Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.

Snegireva LS, Kostik MM, Caroli F, Ceccherini I, Gattorno M, Chasnyk VG.

Rheumatology (Oxford). 2013 Sep;52(9):1731-2. doi: 10.1093/rheumatology/ket121. Epub 2013 Mar 12. No abstract available.

PMID:
23481539
9.

Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis.

Kostik MM, Chikova IA, Avramenko VV, Vasyakina LI, Le Trionnaire E, Chasnyk VG, Levade T.

J Inherit Metab Dis. 2013 Nov;36(6):1079-80. doi: 10.1007/s10545-012-9573-z. Epub 2013 Feb 6.

PMID:
23385296
10.

[Development of telemedicine in country's remote regions].

Liaskovik ATs, Chasnyk VG.

Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2003 Nov-Dec;(6):28-33. Review. Russian. No abstract available.

PMID:
14708193
11.

[Experience in ambulatory care of children who arrived from the regions exposed to radionuclide pollution after the Chernobyl AES accident].

Vorontsov IM, Chasnyk VG, Arkhangel'skaia TB, Bulycheva VI, Petrovtseva VL.

Pediatriia. 1991;(12):59-61. Russian. No abstract available.

PMID:
1838591
12.

[Analysis of the structure of the sinus rhythm in the diagnosis of a rheumatic heart lesion in children].

Chasnyk VG, Kiseleva AA.

Vopr Okhr Materin Det. 1979 Jul;24(7):18-21. Russian. No abstract available.

PMID:
524779

Supplemental Content

Loading ...
Support Center